Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pancreatic Neoplasms × zimberelimab × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Advanced Solid Tumors 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Solid Tumor, Unspecified, Adult 1 Solid Tumor 1 Pharyngeal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Erythrocytosis, Familial, 4 1 Advanced Solid Tumor 1

Interventions

Gemcitabine 151 130-nm albumin-bound paclitaxel 48 Albumin-Bound Paclitaxel 37 Oxaliplatin 29 Fluorouracil 29 Capecitabine 29 pembrolizumab 28 Radiotherapy 25 Leucovorin 25 Irinotecan 25 Erlotinib Hydrochloride 21 Nivolumab 20 Cisplatin 18 Taxes 17 Bevacizumab 14 Radiosurgery 11 Cyclophosphamide 11 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 Carboplatin 10 Paclitaxel 9 Docetaxel 9 Sorafenib 8 Ipilimumab 8 Biopsy 8 trametinib 7 poly ICLC 7 olaparib 7 folfirinox 7 fludarabine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04104672 2026-02-27

ARC-8

Arcus Biosciences, Inc.

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡